These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 30711628)

  • 21. Relamorelin Reduces Vomiting Frequency and Severity and Accelerates Gastric Emptying in Adults With Diabetic Gastroparesis.
    Lembo A; Camilleri M; McCallum R; Sastre R; Breton C; Spence S; White J; Currie M; Gottesdiener K; Stoner E;
    Gastroenterology; 2016 Jul; 151(1):87-96.e6. PubMed ID: 27055601
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ghrelin receptor agonist (TZP-101) accelerates gastric emptying in adults with diabetes and symptomatic gastroparesis.
    Ejskjaer N; Vestergaard ET; Hellström PM; Gormsen LC; Madsbad S; Madsen JL; Jensen TA; Pezzullo JC; Christiansen JS; Shaughnessy L; Kosutic G
    Aliment Pharmacol Ther; 2009 Jun; 29(11):1179-87. PubMed ID: 19298585
    [TBL] [Abstract][Full Text] [Related]  

  • 23. United European Gastroenterology (UEG) and European Society for Neurogastroenterology and Motility (ESNM) consensus on gastroparesis.
    Schol J; Wauters L; Dickman R; Drug V; Mulak A; Serra J; Enck P; Tack J;
    United European Gastroenterol J; 2021 Apr; 9(3):287-306. PubMed ID: 33939892
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of erythromycin on gastric emptying and meal related symptoms in functional dyspepsia with delayed gastric emptying.
    Arts J; Caenepeel P; Verbeke K; Tack J
    Gut; 2005 Apr; 54(4):455-60. PubMed ID: 15753526
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reproducibility of gastric emptying assessed with scintigraphy in patients with upper GI symptoms.
    Desai A; O'Connor M; Neja B; Delaney K; Camilleri M; Zinsmeister AR; Bharucha AE
    Neurogastroenterol Motil; 2018 Oct; 30(10):e13365. PubMed ID: 29722126
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Domperidone is more effective than cisapride in children with diabetic gastroparesis.
    Franzese A; Borrelli O; Corrado G; Rea P; Di Nardo G; Grandinetti AL; Dito L; Cucchiara S
    Aliment Pharmacol Ther; 2002 May; 16(5):951-7. PubMed ID: 11966504
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of chronic oral domperidone therapy on gastrointestinal symptoms, gastric emptying, and quality of life in patients with gastroparesis.
    Soykan I; Sarosiek I; McCallum RW
    Am J Gastroenterol; 1997 Jun; 92(6):976-80. PubMed ID: 9177513
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nizatidine improves clinical symptoms and gastric emptying in patients with functional dyspepsia accompanied by impaired gastric emptying.
    Futagami S; Shimpuku M; Song JM; Kodaka Y; Yamawaki H; Nagoya H; Shindo T; Kawagoe T; Horie A; Gudis K; Iwakiri K; Sakamoto C
    Digestion; 2012; 86(2):114-21. PubMed ID: 22846371
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of Upper Gastrointestinal Symptoms, Gastric Motor Functions, and Associations in Patients with Diabetes at a Referral Center.
    Chedid V; Brandler J; Vijayvargiya P; Park SY; Szarka LA; Camilleri M
    Am J Gastroenterol; 2019 Jan; 114(1):143-154. PubMed ID: 30166634
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of the neurokinin-1 antagonist maropitant on canine gastric emptying assessed by radioscintigraphy and breath test.
    Schmitz S; Fink T; Failing K; Borsch C; Kunz C; Clemence R; Savary-Bataille K; Neiger R
    Tierarztl Prax Ausg K Kleintiere Heimtiere; 2016 Jun; 44(3):163-9. PubMed ID: 27090486
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gastroparesis: separate entity or just a part of dyspepsia?
    Stanghellini V; Tack J
    Gut; 2014 Dec; 63(12):1972-8. PubMed ID: 25260920
    [TBL] [Abstract][Full Text] [Related]  

  • 32. United European Gastroenterology (UEG) and European Society for Neurogastroenterology and Motility (ESNM) consensus on gastroparesis.
    Schol J; Wauters L; Dickman R; Drug V; Mulak A; Serra J; Enck P; Tack J;
    Neurogastroenterol Motil; 2021 Aug; 33(8):e14237. PubMed ID: 34399024
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of cisapride and domperidone in functional (nonulcer) dyspepsia: a meta-analysis.
    Veldhuyzen van Zanten SJ; Jones MJ; Verlinden M; Talley NJ
    Am J Gastroenterol; 2001 Mar; 96(3):689-96. PubMed ID: 11280535
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship between the effects of cisapride on gastric emptying and plasma glucose concentrations in diabetic gastroparesis.
    Horowitz M; Jones KL; Harding PE; Wishart JM
    Digestion; 2002; 65(1):41-6. PubMed ID: 11961342
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Does domperidone, a D2-antagonist alter gastric emptying rates and appetite sensations in healthy adults with high-fat meal? A block-randomised, single-blind placebo-controlled study.
    Markey O; Shafat A
    Ir J Med Sci; 2012 Jun; 181(2):215-9. PubMed ID: 22124998
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changes in patients' symptoms and gastric emptying after Helicobacter pylori treatment.
    Zhang CL; Geng CH; Yang ZW; Li YL; Tong LQ; Gao P; Gao YQ
    World J Gastroenterol; 2016 May; 22(18):4585-93. PubMed ID: 27182168
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Simultaneous measurement of gastric emptying with a simple muffin meal using [13C]octanoate breath test and scintigraphy in normal subjects and patients with dyspeptic symptoms.
    Bromer MQ; Kantor SB; Wagner DA; Knight LC; Maurer AH; Parkman HP
    Dig Dis Sci; 2002 Jul; 47(7):1657-63. PubMed ID: 12141833
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical effects of STW 5 (Iberogast) are not based on acceleration of gastric emptying in patients with functional dyspepsia and gastroparesis.
    Braden B; Caspary W; Börner N; Vinson B; Schneider AR
    Neurogastroenterol Motil; 2009 Jun; 21(6):632-8, e25. PubMed ID: 19220753
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship Between Gastric Emptying Rate and Simultaneously Assessed Symptoms in Functional Dyspepsia.
    Carbone F; De Buysscher R; Van den Houte K; Schol J; Goelen N; Tack J
    Clin Gastroenterol Hepatol; 2022 Mar; 20(3):e429-e437. PubMed ID: 33746098
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A phase 2a, randomized, double-blind 28-day study of TZP-102 a ghrelin receptor agonist for diabetic gastroparesis.
    Ejskjaer N; Wo JM; Esfandyari T; Mazen Jamal M; Dimcevski G; Tarnow L; Malik RA; Hellström PM; Mondou E; Quinn J; Rousseau F; McCallum RW
    Neurogastroenterol Motil; 2013 Feb; 25(2):e140-50. PubMed ID: 23279217
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.